News

The Consortium for Understanding and Reducing Infectious Diseases in Kentucky (CURE-KY) will foster multidisciplinary collaborations to address the burden of infectious diseases.

College of Pharmacy Dean Kip Guy, Ph.D., has researched malaria for nearly two decades. His current work focuses on researching treatments to help underserved populations, and how malaria is like one of Kentucky's most pressing health problems: cancer.

A new study will build upon three decades of research aimed at understanding Borrelia burgdorferi, the bacteria that causes Lyme disease.

Researchers from UK College of Nursing are surveying frontline workers in order to improve infection control practices in health care settings as part of Project Firstline.

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

Kelly G. Pennell, Gill Associate Professor in the Department of Civil Engineering and director of the UK Superfund Research Center (UK-SRC), has co-authored an article detailing lessons learned about stakeholder engagement and risk communication relevant for COVID-19 and school reopening.

A new UK study may provide answers for why so many COVID-19 patients experience blood clotting – and why the risk of thrombosis could remain even after the infection clears.

Dutch is leading the College of Medicine’s COVID-19 Unified Research Experts (CURE) Alliance team, which brings together faculty expertise from multiple disciplines across the university to focus on advising COVID-19 patient care and clinical trials based on emerging research.

CCTS is partnering with NCATS, the National Center for Data to Health, and around 60 other clinical institutions affiliated with the NCATS Clinical and Translational Science Awards Program to leverage big data in the fight against COVID-19.

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.